Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.
about
Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).Evaluation of combinatorial vaccines against anthrax and plague in a murine modelVaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines.Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein.Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisInterplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Vaccinating against Helicobacter pylori in the developing world.
P2860
Q30429806-02C64BEE-0093-42AC-AB04-D4084B21C5A5Q33283821-CA485D7E-A774-4EB2-89EA-79CDD9F32AC5Q33798458-0AFFE09D-5D3A-4C46-896D-39CCAF140B62Q33840918-4EFA42AD-7010-4EAB-A2FA-1C9277B534EDQ33946563-48F0B5BE-8FBA-4FDF-97AC-A90513ECE41FQ34008465-79A09C56-A9FF-4DC6-9C63-1A6AB033F379Q34059460-2A68C034-369B-41A1-B179-BE576025AAF4Q34121150-8EEA8276-88FC-4F5F-A14D-AEA1CFF6AD40Q34131697-035A543B-6600-4CD7-BD2F-EB13CADC5F8AQ37591512-446C2E3E-DBB2-4090-AAC4-B465D831C54F
P2860
Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effectiveness of a vaccine com ...... against systemic candidiasis.
@ast
Effectiveness of a vaccine com ...... against systemic candidiasis.
@en
Effectiveness of a vaccine com ...... against systemic candidiasis.
@nl
type
label
Effectiveness of a vaccine com ...... against systemic candidiasis.
@ast
Effectiveness of a vaccine com ...... against systemic candidiasis.
@en
Effectiveness of a vaccine com ...... against systemic candidiasis.
@nl
prefLabel
Effectiveness of a vaccine com ...... against systemic candidiasis.
@ast
Effectiveness of a vaccine com ...... against systemic candidiasis.
@en
Effectiveness of a vaccine com ...... against systemic candidiasis.
@nl
P2093
P2860
P1476
Effectiveness of a vaccine com ...... against systemic candidiasis.
@en
P2093
J D Clements
L Cárdenas-Freytag
P2860
P304
P407
P577
1999-02-01T00:00:00Z